COVID‐19 in Parkinson’s Disease Patients Living in Lombardy, Italy

Background It is unknown whether patients with PD are at greater risk of COVID‐19, what their risk factors are, and whether their clinical manifestations differ from the general population. Objectives The study aimed to address all these issues. Methods In a case‐controlled survey, we interviewed 1,...

Full description

Saved in:
Bibliographic Details
Published in:Movement Disorders 2020-07, Vol.35 (7), p.1089-1093
Main Authors: Fasano, Alfonso, Cereda, Emanuele, Barichella, Michela, Cassani, Erica, Ferri, Valentina, Zecchinelli, Anna Lena, Pezzoli, Gianni
Format: Article
Language:English
Subjects:
Age Factors
Aged
Aged, 80 and over
Betacoronavirus
Brief Report
Case-Control Studies
Chronic obstructive pulmonary disease
Comorbidity
Coronavirus Infections - epidemiology
Coronavirus Infections - mortality
Coronavirus Infections - physiopathology
COVID-19
Dyspnea - epidemiology
Dyspnea - physiopathology
Female
Hospitalization - statistics & numerical data
Humans
Italy - epidemiology
Lung diseases
Male
Middle Aged
Movement disorders
Neurodegenerative diseases
Obesity - epidemiology
Obstructive lung disease
Pandemics
Parkinson Disease - epidemiology
Parkinson's disease
Pneumonia, Viral - epidemiology
Pneumonia, Viral - mortality
Pneumonia, Viral - physiopathology
Population studies
Protective Factors
Pulmonary Disease, Chronic Obstructive - epidemiology
Risk Factors
SARS-CoV-2
Special Series
Supplements
Tertiary Care Centers
Vitamin D
Vitamin D - therapeutic use
Vitamins - therapeutic use
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!